Article
India pharma industry explores new export markets amid US tariff risks
5 minutes
China remains a formidable competitor, particularly in complex biologics, where its manufacturers maintain significant scale.
Industry Insights
Home / Industry Insights
More Stories
- Industry Article — Before saying yes to the medical test, know the risks and benefits
- Industry Article — Recyclable, high-barrier polypropylene pharma blister revealed by ACG
- Industry Article — Pharma leaders say India must now move from generics to innovation
- Industry Article — Which Roti Is Best For Diabetics? Expert Weighs In
- Industry News — Govt plans framework to grade private, state hospitals on quality, safety: Report
- Industry Article — Can exercise lower breast cancer risk? Oncologist explains which workouts women should focus on.
- Industry Article — Why is Asia Set to Dominate the Future of Pharma R&D?
- Industry Article — Role of Nutraceuticals in Cardiology Practice
- Industry Article — India's healthcare ambition goes beyond affordable treatment
- Industry Article — 44-year-old gastroenterologist shares ‘anti-ageing secrets’ he wishes he knew in his 20s: ‘Sleep is best longevity tool’
- Industry News — Centre proposes changes to medical device rules on sterilisation, testing fees
- Industry News — Indian pharma firms plan ₹45,000-cr capex in FY26, says ICRA
- Industry News — Pharma sector growth stays strong in FY27; margins to soften as costs escalate: Ind-Ra